If you liked this article you might like

More Squawk from Jim Cramer: Mylan (MYL) EpiPens 'Should Not Be Just for Rich People'
BTIG's Chiang Explains on CNBC Why He's Sticking With Mylan (MYL)
Mylan (MYL) Stock Slides, Citigroup: EpiPen Scrutiny Could Drive Multiples Down
A Backlash Materializes Against Soaring EpiPen Prices